UK cancer mutation testing firm Biofidelity raises $12m
Cambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect mutations quicker than current approaches like gene sequencing. The Series A comes just a few months after Biofidelity launched with seed funding from Longwall Ventures and private… Read More »UK cancer mutation testing firm Biofidelity raises $12m
